ORIGINAL RESEARCH article

Front. Pediatr.

Sec. Pediatric Orthopedics

Volume 13 - 2025 | doi: 10.3389/fped.2025.1485277

Ultrasound-Guided Coracobrachialis Plane Musculocutaneous Nerve Block for Perioperative Analgesia in Pediatric Gartland Type III Supracondylar Humerus Fracture: a Prospective Pilot Study Gao et al. SHF Coracobrachialis plane musculocutaneous nerve block

Provisionally accepted
Tianyi  GaoTianyi Gao1Zhuorun  SongZhuorun Song2Shunyi  LuShunyi Lu2Nan  SongNan Song2Wentao  YuWentao Yu1Huilin  YangHuilin Yang2Jun  ZouJun Zou2Qian  WangQian Wang1Jun  GeJun Ge2*
  • 1Children's Hospital of Soochow University, Suzhou, Jiangsu Province, China
  • 2The First Affiliated Hospital of Soochow University, Suzhou, China

The final, formatted version of the article will be published soon.

Purpose: Perioperative pain management in children with Gartland Type III supracondylar humerus fractures (SHF) is crucial but often inadequately addressed, leading to significant pain experiences. This study aimed to evaluate the efficacy and safety of coracobrachialis plane musculocutaneous nerve block (Cora-MNB) compared to supraclavicular brachial plexus block (SC-BPB) for analgesia in pediatric Gartland Type III SHF patients.: A prospective pilot study enrolled 105 pediatric patients with Gartland Type III SHF was performed. Primary outcome was the postoperative FLACC scale measured at 12 hours postoperatively. Secondary outcomes included FLACC scale measured at 1 hour, 6 hours and 24 hours postoperatively. They also included postoperative thumb and shoulder strength, opioid use, NSAIDs use, length of hospital stays, patient satisfaction, surgeon satisfaction, operation time and puncture channels.One hundred and five patients were randomized allocated between groups.Results: Patients receiving Cora-MNB showed superior analgesia, with median postoperative FLACC pain scores at 12 h reduced by 40% (Cora-MNB: 3.00(2.00) vs SC-BPB: 5.00(2.00), p<0.001***). Thumb extensor weakness incidence decreased significantly (Cora-MNB: 13.5% vs SC-BPB: 84.9%, p<0.001***).Shoulder mobility preservation was achieved in 98.08% of Cora-MNB cases versus 94.34% with SC-BPB (p<0.001***). While opioid consumption showed no intergroup difference, Cora-MNB reduced NSAID rescue times (Cora-MNB: 0.00(1.00) vs SC-BPB: 1.00(1.00), p=0.0014**). Procedure duration favored Cora-MNB (4.54±1.21(min) vs 9.02±1.94(min), T=14.32, 95%CI: 3.88 -5.12, p<0.001***), with higher surgical and parental satisfaction scores. Hospital stays remained comparable (1.60±0.66(days) vs 1.56±0.67(days), p=0.98).Cora-MNB proves to be a safe and effective approach for anesthesia in pediatric SHF cases, offering superior analgesic outcomes, reduced NSAIDs usage, improved shoulder functionality, and high satisfaction levels without extending the hospital stay. This study supports the implementation of Cora-MNB as a valuable technique in perioperative pain management for pediatric SHF patients.

Keywords: coracobrachialis plane, musculocutaneous nerve block, Pediatric supracondylar humerus fracture, Perioperative analgesia, Pain Management, prospective pilot study

Received: 23 Aug 2024; Accepted: 04 Apr 2025.

Copyright: © 2025 Gao, Song, Lu, Song, Yu, Yang, Zou, Wang and Ge. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Jun Ge, The First Affiliated Hospital of Soochow University, Suzhou, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Research integrity at Frontiers

94% of researchers rate our articles as excellent or good

Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


Find out more